scholarly journals Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial

10.2196/23123 ◽  
2020 ◽  
Vol 8 (11) ◽  
pp. e23123
Author(s):  
Carlos O'Connor-Reina ◽  
Jose Maria Ignacio Garcia ◽  
Elisa Rodriguez Ruiz ◽  
Maria Del Carmen Morillo Dominguez ◽  
Victoria Ignacio Barrios ◽  
...  
Keyword(s):  
Sleep Quality ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Intervention Group ◽  
Oxygen Desaturation ◽  
Control Group ◽  
Desaturation Index ◽  
Myofunctional Therapy ◽  
Oxygen Desaturation Index

Background Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea–hypopnea syndrome (OSAHS) to perform oropharyngeal exercises. Objective We conducted a pilot randomized trial to evaluate the effects of the app in patients with severe OSAHS. Methods Forty patients with severe OSAHS (apnea–hypoxia index [AHI]>30) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. Anthropometric measures, Epworth Sleepiness Scale (0-24), Pittsburgh Sleep Quality Index (0-21), Iowa Oral Performance Instrument (IOPI) scores, and oxygen desaturation index were measured before and after the intervention. Results After the intervention, 28 patients remained. No significant changes were observed in the control group; however, the intervention group showed significant improvements in most metrics. AHI decreased by 53.4% from 44.7 (range 33.8-55.6) to 20.88 (14.02-27.7) events/hour (P<.001). The oxygen desaturation index decreased by 46.5% from 36.31 (27.19-43.43) to 19.4 (12.9-25.98) events/hour (P=.003). The IOPI maximum tongue score increased from 39.83 (35.32-45.2) to 59.06 (54.74-64.00) kPa (P<.001), and the IOPI maximum lip score increased from 27.89 (24.16-32.47) to 44.11 (39.5-48.8) kPa (P<.001). The AHI correlated significantly with IOPI tongue and lip improvements (Pearson correlation coefficient −0.56 and −0.46, respectively; both P<.001). The Epworth Sleepiness Scale score decreased from 10.33 (8.71-12.24) to 5.37 (3.45-7.28) in the app group (P<.001), but the Pittsburgh Sleep Quality Index did not change significantly. Conclusions Orofacial exercises performed using an mHealth app reduced OSAHS severity and symptoms, and represent a promising treatment for OSAHS. Trial Registration Spanish Registry of Clinical Studies AWGAPN-2019-01, ClinicalTrials.gov NCT04438785; https://clinicaltrials.gov/ct2/show/NCT04438785

scholarly journals Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial (Preprint)

2020 ◽  
Author(s):  
Carlos O'Connor-Reina ◽  
Jose Maria Ignacio Garcia ◽  
Elisa Rodriguez Ruiz ◽  
Maria Del Carmen Morillo Dominguez ◽  
Victoria Ignacio Barrios ◽  
...  
Keyword(s):  
Sleep Quality ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Intervention Group ◽  
Oxygen Desaturation ◽  
Control Group ◽  
Desaturation Index ◽  
Myofunctional Therapy ◽  
Oxygen Desaturation Index

BACKGROUND Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea–hypopnea syndrome (OSAHS) to perform oropharyngeal exercises. OBJECTIVE We conducted a pilot randomized trial to evaluate the effects of the app in patients with severe OSAHS. METHODS Forty patients with severe OSAHS (apnea–hypoxia index [AHI]&gt;30) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. Anthropometric measures, Epworth Sleepiness Scale (0-24), Pittsburgh Sleep Quality Index (0-21), Iowa Oral Performance Instrument (IOPI) scores, and oxygen desaturation index were measured before and after the intervention. RESULTS After the intervention, 28 patients remained. No significant changes were observed in the control group; however, the intervention group showed significant improvements in most metrics. AHI decreased by 53.4% from 44.7 (range 33.8-55.6) to 20.88 (14.02-27.7) events/hour (<i>P</i>&lt;.001). The oxygen desaturation index decreased by 46.5% from 36.31 (27.19-43.43) to 19.4 (12.9-25.98) events/hour (<i>P</i>=.003). The IOPI maximum tongue score increased from 39.83 (35.32-45.2) to 59.06 (54.74-64.00) kPa (<i>P</i>&lt;.001), and the IOPI maximum lip score increased from 27.89 (24.16-32.47) to 44.11 (39.5-48.8) kPa (<i>P</i>&lt;.001). The AHI correlated significantly with IOPI tongue and lip improvements (Pearson correlation coefficient −0.56 and −0.46, respectively; both <i>P</i>&lt;.001). The Epworth Sleepiness Scale score decreased from 10.33 (8.71-12.24) to 5.37 (3.45-7.28) in the app group (<i>P</i>&lt;.001), but the Pittsburgh Sleep Quality Index did not change significantly. CONCLUSIONS Orofacial exercises performed using an mHealth app reduced OSAHS severity and symptoms, and represent a promising treatment for OSAHS. CLINICALTRIAL Spanish Registry of Clinical Studies AWGAPN-2019-01, ClinicalTrials.gov NCT04438785; https://clinicaltrials.gov/ct2/show/NCT04438785

scholarly journals Availability of a Flavored Beverage and Impact on Children’s Hydration Status, Sleep, and Mood

Nutrients ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1757
Author(s):  
Michael R. Szymanski ◽  
Gabrielle E. W. Giersch ◽  
Margaret C. Morrissey ◽  
Courteney L. Benjamin ◽  
Yasuki Sekiguchi ◽  
...  
Keyword(s):  
Sleep Quality ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Intervention Group ◽  
Urine Osmolality ◽  
Urine Specific Gravity ◽  
Hydration Status ◽  
Control Group ◽  
Profile Of Mood States ◽  
Urine Color

Euhydration remains a challenge in children due to lack of access and unpalatability of water and to other reasons. The purpose of this study was to determine if the availability/access to a beverage (Creative Roots®) influences hydration in children and, therefore, sleep quality and mood. Using a crossover investigation, 46 participants were randomly assigned to a control group (CON) or an intervention group and received Creative Roots® (INT) for two-week periods. We recorded daily first morning and afternoon urine color (Ucol), thirst perception, and bodyweight of the two groups. Participants reported to the lab once per week and provided first morning urine samples to assess Ucol, urine specific gravity (USG), and urine osmolality (Uosmo). Participants also completed the questionnaires Profile of Mood States-Adolescents (POMS-a) and Pittsburgh Sleep Quality Index (PSQI). Dependent t-tests were used to assess the effects of the intervention on hydration, mood, and sleep quality. Uosmo was greater and Ucol was darker in the control group (mean ± SD) [Uosmo: INT = 828 ± 177 mOsm·kg−1, CON = 879 ± 184 mOsm·kg−1, (p = 0.037], [Ucol:INT = 5 ± 1, CON = 5 ± 1, p = 0.024]. USG, POMS-a, and PSQI were not significant between the groups. At-home daily afternoon Ucol was darker in the control group [INT = 3 ± 1, CON = 3 ± 1, p = 0.022]. Access to Creative Roots® provides a small, potentially meaningful hydration benefit in children. However, children still demonstrated consistent mild dehydration based on Uosmo, despite consuming the beverage.

scholarly journals Clinical Efficacy of a New Robot-assisted Gait Training System for Acute Stroke Patients

2021 ◽  
Author(s):  
Andy Chien ◽  
Fei-Chun Chang ◽  
Nai-Hsin Meng ◽  
Pei-Yu Yang ◽  
Ching Huang ◽  
...  
Keyword(s):  
Sleep Quality ◽  
Acute Stroke ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Gait Training ◽  
Training System ◽  
Control Group ◽  
Stroke Patients ◽  
Robot Assisted ◽  
Significant Difference

Abstract Purpose Robot-assisted gait rehabilitation has been proposed as a plausible supplementary rehabilitation strategy in stroke rehabilitation in the last decade. However, its exact benefit over traditional rehabilitation remain sparse and unclear. It is therefore the purpose of the current study to comparatively investigate the clinical benefits of the additional robot-assisted training in acute stroke patients compared to standard hospital rehabilitation alone. Methods Ninety acute stroke patients (< 3 month) were recruited. All participants received the standard hospital neurorehabilitation comprises 45–60 min sessions daily for 3 weeks. Sixty patients also received an additional 30 min of robot-assisted gait training with the HIWIN MRG-P100 gait training system after each of the standard neurorehabilitation session. Outcome measures included: 1. Berg Balance Scale (BBS); 2. Brunnstrom Stage; 3. Pittsburgh Sleep Quality Index and 4. Taiwanese Depression Questionnaire (TDQ) which were assessed pre-treatment and then after every five training sessions. Results Both groups demonstrated significant improvement pre- and post-treatment for the BBS (robotic group p = 0.023; control group p = 0.033) but no significant difference (p > 0.1) between the groups were found. However, the robotic training group had more participants demonstrating larger BBS points of improvement as well as greater Brunnstrom stage of improvement, when compared to the control group. No significant within and between group statistical differences (p > 0.3) were found for Pittsburgh Sleep Quality Index and Taiwanese Depression Questionnaire. Conclusion The addition of robotic gait training on top of standard hospital neurorehabilitation for acute stroke patients appear to produce a slightly greater improvement in clinical functional outcomes, which is not transferred to psychological status.

scholarly journals Evaluation of quality of sleep in women with stress urinary incontinence before and after surgical correction

2018 ◽  
Vol 16 (2) ◽  
Author(s):  
Josyandra Paula de Freitas ◽  
Mariana Pereira Inácio Silvestri ◽  
César Eduardo Fernandes ◽  
Emerson de Oliveira
Keyword(s):  
Urinary Incontinence ◽  
Stress Urinary Incontinence ◽  
Sleep Quality ◽  
Sleep Disorder ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Quality Of Sleep ◽  
Before And After

ABSTRACT Objective: To evaluate the quality of sleep in women with urinary incontinence before and after sling surgery. Methods: A prospective study of case series of women with urodynamic diagnosis of stress urinary incontinence. To evaluate the subjective quality of sleep, two specific questionnaires were used and validated for the Portuguese Language: Epworth Sleepiness Scale and Pittsburgh Sleep Quality Index. The questionnaires were applied before and 6 months after surgical repair. Results: When analyzing the Epworth Sleepiness Scale, there was an improvement in sleep quality (p=0.0401). For the Pittsburgh Sleep Quality Index, only for sleep disorder there was improvement in quality of sleep after surgery (p=0.0127). Conclusion: Women with urinary incontinence, submitted to surgery with sling, showed improvement in both quality of sleep and sleep disorder.

Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial

2019 ◽  
Vol 33 (11) ◽  
pp. 1388-1394 ◽  
Author(s):  
Bing Cao ◽  
Caroline Park ◽  
Joshua D Rosenblat ◽  
Yan Chen ◽  
Michelle Iacobucci ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Sleep Quality ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Severity Index ◽  
Major Depressive ◽  
Insomnia Severity Index ◽  
Insomnia Severity

Background Sleep disturbances are frequently reported in patients with major depressive disorder. We aimed to investigate the effects of vortioxetine on sleep quality and association between changes in sleep and treatment response. Methods: This study is a post-hoc analysis of a clinical trial that sought to evaluate the sensitivity to cognitive change of THINC-integrated tool in patients with major depressive disorder. In total, 92 patients (aged 18 to 65) meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for moderate or severe major depressive disorder and 54 healthy controls were included. All patients received open-label vortioxetine (10–20 mg/day, flexibly dosed) for 8 weeks. Herein, the primary outcomes of interest were changes in sleep, as measured by the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index, between weeks 0, 2, and 8. The association between changes in sleep and depressive symptom severity was secondarily assessed. Results: We observed that sleep, as indicated by scores of Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index, was significantly poorer in patients with major depressive disorder compared to healthy controls at weeks 0, 2, and 8 ( p < 0.05). Among patients with major depressive disorder, we observed significant improvements on the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index between weeks 0 and 8 ( p < 0.05). We observed a significant association between improvements on the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Insomnia Severity Index and improvement of depressive symptoms. Conclusion: Improvement of depressive symptoms in major depressive disorder patients treated with vortioxetine was associated with significant improvements in sleep. Furthermore, improvements in sleep were predictive of antidepressant response and were linearly correlated with improvement in overall depressive symptom severity.

scholarly journals Διαταραχές κατά τον ύπνο σε ασθενείς με ιδιοπαθή πνευμονική ίνωση (ΙΠΙ) και συσχετισμός αυτών με παραμέτρους αναπνευστικής και καρδιαγγειακής λειτουργίας και με δείκτες ποιότητος ζωής

2015 ◽  
Author(s):  
Ελένη Σταγάκη
Keyword(s):  
Sleep Quality ◽  
Epworth Sleepiness Scale ◽  
Functional Outcomes ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Fatigue Severity Scale ◽  
Severity Scale ◽  
Sleep Questionnaire ◽  
Fatigue Severity

ΠΕΡΙΛΗΨΗΕισαγωγήΗ ιδιοπαθής πνευμονική ίνωση (ΙΠΙ) είναι μια χρονία παρεγχυματική νόσος του πνεύμονα αγνώστου αιτιολογίας, η οποία συνδέεται με τον ιστοπαθολογικό τύπο της συνήθους διάμεσης πνευμονίας (UIP). Είναι η συχνότερη από τις ιδιοπαθείς διάμεσες πνευμονίες και έχει κακή πρόγνωση. Δεδομένου ότι καμία έως τώρα θεραπευτική αγωγή δεν έχει αποδειχθεί αποτελεσματική στην αντιμετώπιση της ΙΠΙ, το πρωταρχικό μέλημα των θεραπόντων ιατρών πρέπει να είναι η βελτίωση ποιότητας ζωής των ασθενών αυτών, με έμφαση στην αναγνώριση και αντιμετώπιση των συννοσηροτήτων της νόσου, όπως είναι οι διαταραχές κατά τον ύπνο.ΣκοπόςΟ σκοπός της διδακτορικής διατριβής ήταν η αναγνώριση των διαταραχών ύπνου και οι ημερήσιες επιπτώσεις αυτών, σε αμιγή πληθυσμό ασθενών με Ιδιοπαθή Πνευμονική Ίνωση. Περιλάμβανε δύο μελέτες. Η πρώτη μελέτη πραγματοποιήθηκε στη Μονάδα Μελέτης Ύπνου Γ.Ν.Α. «Σισμανόγλειο» και η δεύτερη προέκυψε με συνεργασία και άλλων πνευμονολογικών κλινικών. Κάθε μια από τις δυο μελέτες επικεντρώνεται σε διαφορετικές παραμέτρους των διαταραχών ύπνου.Στην πρώτη μελέτη («Mελέτη 1») ο σκοπός μας ήταν η περιγραφή της ποιότητας ύπνου και των ημερήσιων επιπτώσεων των πιθανών διαταραχών του. Η δεύτερη μελέτη («Μελέτη 2») στοχεύει στην εκτίμηση της συχνότητας του συνδρόμου απνοιών υποπνοιών κατά τον ύπνο και στην αναγνώριση πιθανής συσχέτισης μεταξύ παραμέτρων της πολυκαταγραφικής μελέτης ύπνου με το δείκτη μάζας σώματος (BMI), παραμέτρων οξυγόνωσης κατά τη διάρκεια το ύπνου και των τιμών από τις πνευμονικές λειτουργίες του πνεύμονα.Υλικό και μεθοδολογία «Μελέτης 1»Στην πρώτη μελέτη συμμετείχαν 15 ασθενείς με ΙΠΙ και ομάδα ελέγχου αποτελούμενη από 15 υγιείς εθελοντές με αντιστοιχία ηλικίας και δείκτη μάζας σώματος. Η ποιότητα ύπνου και οι ημερήσιες επιπτώσεις εκτιμήθηκαν με κλινικό ιστορικό και τα ερωτηματολόγια Pittsburgh Sleep Quality Index (PSQI), Functional Outcomes in Sleep Questionnaire (FOSQ), Fatigue Severity Scale (FSS), Epworth Sleepiness Scale και πολυκαταγραφική μελέτη ύπνου (ΠΚΜΥ).Αποτελέσματα «Μελέτης 1»Η πρώτη μελέτη ανέδειξε διαφορές στατιστικά σημαντικές μεταξύ των ασθενών με ΙΠΙ και της ομάδας ελέγχου σε ότι αφορά: την αποτελεσματικότητα ύπνου, το στάδιο 1, το στάδιο ύπνου βραδέων κυμάτων, το δείκτη αφυπνίσεων, τον κορεσμό οξυγόνου (μέσο και ελάχιστο). Επίσης, ο ολικός χρόνος ύπνου με κορεσμό Ο2 κάτω από 90% ήταν 34.3 ±37.3% έναντι 0.9±1.2% της ομάδας ελέγχου (p=0.002). Η ταχύπνοια που παρουσίαζαν οι ασθενείς κατά την εγρήγορση επέμενε και κατά τον ύπνο. Η ποιότητα ύπνου και ημερήσια λειτουργικότητα ήταν μετρίως με σοβαρά διαταραγμένες, βάσει των σκορ των ερωτηματολογίων PSQI και FOSQ. Η συνολική βαθμολογία στο ερωτηματολόγιο FOSQ είχε αρνητική συσχέτιση με τον ολικό χρόνο ύπνου με κορεσμό Ο2 κάτω από 90% (p=0.01, r= -0.62), ενώ η βαθμολογία του FSS ερωτηματολογίου συσχετίστηκε με τον ολικό χρόνο ύπνου με κορεσμό Ο2 κάτω από 90% και με το μέσο όρο κορεσμού οξυγόνου κατά τον ύπνο (p = 0.002, r = 0.74, and p = 0.007, r = –0.66, αντίστοιχα). Δεν διαπιστώθηκε στατιστικά σημαντική διαφορά στον υπνοαπνοϊκό δείκτη μεταξύ των ασθενών με ΙΠΙ και της ομάδας ελέγχου (9.2±6.7 έναντι 7.1±4.5, αντίστοιχα, p=0.31). Εντούτοις 67% των ασθενών με ΙΠΙ είχε υπνοαπνοϊκό δείκτη>5.Υλικό και μεθοδολογία «Μελέτης 2»Στη δεύτερη μελέτη έλαβαν μέρος 34 νεοδιαγνωσθέντες ασθενείς με ΙΠΙ (σε αυτούς περιλαμβάνεται και ο πληθυσμός των ασθενών που είχαν συμμετάσχει στην πρώτη μελέτη). Όλοι υπεβλήθησαν σε πολυκαταφγραφική μελέτη ύπνου (ΠΚΜΥ) καθόλη τη διάρκεια του νυχτερινού ύπνου.Αποτελέσματα «Μελέτης 2»Ο συνολικός ΔΑΥ ήταν 9.4±8.2/ώρα ύπνου. ΔΑΥ 0-5, 5-15, και >15/ώρα ύπνου παρατηρήθηκε σε 14 (41%), 15 (44%), και 5 ασθενείς (15%), αντίστοιχα. Επίσης, διαπιστώθηκε στατιστικά σημαντική αρνητική συσχέτιση της ολικής πνευμονικής χωρητικότητας (TLC) και του ΔΑΥ κατά τον ύπνο REM (p=0.03, r=-0.38). Η διαχυτική ικανότητα του πνεύμονα DLCO συσχετίστηκε με τη μέση τιμή κορεσμού οξυγόνου κατά τον ύπνο (p= 0.02, r=0.39). Τέλος και στη δεύτερη μελέτη παρατηρήθηκε ελάττωση της αποτελεσματικότητας του ύπνου (64.9±14.5%) και του σταδίου REM (10.1±4.8%) και αύξηση του σταδίου 1 (15.1±7.7%).Συμπεράσματα Από όσο μπορούμε να γνωρίζουμε οι δυο μελέτες μας είναι από τις πρώτες προοπτικές μελέτες που διερευνούν την πιθανότητα διαταραχών της αναπνοής κατά τον ύπνο σε ασθενείς με πρόσφατη διάγνωση ΙΠΙ πριν την έναρξη οποιασδήποτε αγωγής και/ή νυχτερινής οξυγονοθεραπείας. Τα αποτελέσματά τους αποδεικνύουν σημαντικές διαταραχές ύπνου στους ασθενείς με ΙΠΙ που συνεπάγονται σοβαρούς περιορισμούς στη φυσική και κοινωνική δραστηριότητα. Σημαντικές συσχετίσεις διαπιστώθηκαν μεταξύ παραμέτρων νυχτερινής οξυγόνωσης και του επιπέδου της ημερήσιας δραστηριότητας. Επιπλέον, γίνεται φανερό ότι το σύνδρομο απνοιών - υποπνοιών ύπνου είναι συχνό στους ασθενείς με ΙΠΙ, γεγονός που επιβεβαιώνεται και από μετέπειτα μελέτες, ώστε στις πρόσφατες οδηγίες για την ΙΠΙ το ΣΑΥΥ να περιλαμβάνεται για πρώτη φορά σαν συννοσηρότητα της νόσου και να ενθαρρύνεται η έρευνα προς αυτήν την κατεύθυνση. Εάν μέναμε στις απόψεις του παρελθόντας ότι δηλαδή το ΣΑΥΥ δεν υπάρχει σε ασθενείς με ΙΠΙ αυτό δεν θα γινόταν ποτέ.Τα ερωτήματα που προκύπτουν στη συνέχεια είναι, πρώτον εάν οι ασθενείς με ΙΠΙ θα έπρεπε να ελέγχονται συστηματικά για την ύπαρξη διαταραχών κατά τον ύπνο, που πιθανά μέχρι τώρα υποδιαγιγνώσκονται και δεύτερον εάν οι ασθενείς με ΙΠΙ και ΔΑΥ ≥5, που αντιπροσωπεύουν θα έπρεπε να αντιμετωπισθούν με CPAP, με στόχο τη βελτίωση της ποιότητας ύπνου και κατ’ επέκταση της ποιότητας ζωής, δεδομένης της έλλειψης αποτελεσματικής θεραπείας για την ΙΠΙ μέχρι τώρα.

scholarly journals Reliability and Validity of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale in Older Men

2011 ◽  
Vol 67A (4) ◽  
pp. 433-439 ◽  
Author(s):  
A. P. Spira ◽  
S. A. Beaudreau ◽  
K. L. Stone ◽  
E. J. Kezirian ◽  
L.-Y. Lui ◽  
...  
Keyword(s):  
Sleep Quality ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Reliability And Validity ◽  
Older Men

scholarly journals Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with Fibromyalgia

2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
Guillermo A. Matarán-Peñarrocha ◽  
Adelaida María Castro-Sánchez ◽  
Gloria Carballo García ◽  
Carmen Moreno-Lorenzo ◽  
Tesifón Parrón Carreño ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Placebo Group ◽  
Sleep Quality ◽  
Treatment Period ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Intervention Group ◽  
Craniosacral Therapy

Fibromyalgia is considered as a combination of physical, psychological and social disabilities. The causes of pathologic mechanism underlying fibromyalgia are unknown, but fibromyalgia may lead to reduced quality of life. The objective of this study was to analyze the repercussions of craniosacral therapy on depression, anxiety and quality of life in fibromyalgia patients with painful symptoms. An experimental, double-blind longitudinal clinical trial design was undertaken. Eighty-four patients diagnosed with fibromyalgia were randomly assigned to an intervention group (craniosacral therapy) or placebo group (simulated treatment with disconnected ultrasound). The treatment period was 25 weeks. Anxiety, pain, sleep quality, depression and quality of life were determined at baseline and at 10 minutes, 6 months and 1-year post-treatment. State anxiety and trait anxiety, pain, quality of life and Pittsburgh sleep quality index were significantly higher in the intervention versus placebo group after the treatment period and at the 6-month follow-up. However, at the 1-year follow-up, the groups only differed in the Pittsburgh sleep quality index. Approaching fibromyalgia by means of craniosacral therapy contributes to improving anxiety and quality of life levels in these patients.

Criterion validity of the Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale for the diagnosis of sleep disorders

2014 ◽  
Vol 15 (4) ◽  
pp. 422-429 ◽  
Author(s):  
Takeshi Nishiyama ◽  
Tomoki Mizuno ◽  
Masayo Kojima ◽  
Sadao Suzuki ◽  
Tsuyoshi Kitajima ◽  
...  
Keyword(s):  
Sleep Quality ◽  
Sleep Disorders ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Criterion Validity
Sign in / Sign up

Export Citation Format

Share Document